. RegameyCLibkeRDEngelkingER: Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. J Infect Dis1975; 131: 291–294.
2.
. MoelleringRCJrSwartzMN: Drug therapy: The newer cephalosporins. N Engl J Med1976; 294: 24–29.
3.
. WeinsteinAJ: The cephalosporins: Activity and clinical use. Drugs1980; 19: 137–154.
4.
. MangiRJKundargiRSQuintilianiR: Development of meningitis during cephalothin therapy. Ann Intern Med1973; 78: 347–351.
5.
. NeuHC: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis1978; 137 (suppl):S80–S87.
6.
. Cefamandole and cefoxitin. Medical Letter1979; 21: 13–15.
7.
. Two new oral cephalosporins. Medical Letter1979; 21: 85–87.
8.
. McCrackenGHJr: The cephalosporins: A perspective on their properties and indications for use in pediatrics. J Int Med Res1980; 8 (suppl):45–49.
9.
. RussellADRogersDT: Antibacterial activity of a new cephalosporin, cefotaxime. J Appl Bacteriol1980; 49: 137–141.
10.
. ThompsonRL: The cephalosporins. Mayo Clin Proc1977; 52: 625–630.
11.
. NightingaleCHGreeneDSQuintilianiR: Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci1975; 64: 1899–1927.
12.
. NeuHCAswapokeePFuKP: Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses. Clin Pharmacol Ther1980; 27: 677–685.
